By G HossainPosted on July 30, 2026Posted in Pharmaceutical & Bio Science, UncategorizedTagged bio science career, blogs, business career news, career tips, job blog, job news, RJF Pharmaceutical Jobs Calls for Regeneron to step up dealmaking have intensified as the company has established an $18 billion cash pile and suffered clinical trial setbacks. Regeneron’s ‘aversion’ to M&A questioned as bumper Q2 builds war chest Post navigation Daiichi’s pipeline falls behind rivals as cash flow nears peak: analystsBMS’ ‘big beat’ clouded by Cobenfy, heart disease data delays
